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Abstract
Purpose – The purpose of this paper is to identify the health problems and treatment needs of
drug-misusing offenders and to draw out the implications of the findings for health education and
prevention.
Design/methodology/approach – This analysis is based on data collected as part of the New
English and Welsh Arrestee Drug Abuse Monitoring (NEW-ADAM) programme. The survey was
based on interviews and urine sample collection with over 3,000 arrestees.
Findings – The research found that young arrestees experienced a wide range of drug-related and
general health problems. The implications of this are discussed in the context of programmes
implemented as part of the government’s drug strategy.
Originality/value – The NEW-ADAM surveys provide an original source of information on the
drug and general health needs of young people at the first point of entry in the criminal justice system.
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Paper type Research paper
Introduction
There are a wide variety of health problems that can be experienced by drug users,
including dependency, infectious diseases, harmful physiological effects, and risk of
overdose and death. These problems are important not only for the individual drug
user, but also for those people (such as family members or the police) who come into
regular contact with them. They are also important in that they increase the burden on
the health service and its personnel, including general practitioners and hospital-based
services.
Drug users have a wider range of health problems than members of the general
population (Neale, 2004) (if you say research shows you need more than one ref) Brooke
et al. (2000) studied the health backgrounds of prisoners on remand with substance
misuse problems and found that they reported more childhood adversity, conduct
disorder, self-harm, past psychiatric treatment and current mood disorder than the
general population. There is also evidence that drug users contract infections at a
higher rate than the general population. The Health Protection Agency (2005) reported
a range of diseases among drug users including abscesses, skin infections, MRSA,
wound botulism, and tetanus. Gossop et al. (2002) found that the annual mortality rate
among users in treatment in the UK was about six times higher than that for a general,
age-matched population.
Drug misusers also commonly report higher rates of mental health disorders than
the general population (Farrell et al., 1998). A study by Weaver et al. (2002) in the UK
found that 75 per cent of users of drug services experienced mental health problems.
Most had affective disorders (e.g. depression) or anxiety disorders. Approximately
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one-third of the sample experienced co-morbidity (co-occurrence of a number of
psychiatric disorders). Another study of psychological health problems among
patients in treatment found that one in five drug users had previously received
treatment for a psychiatric health problem other than substance misuse (Marsden et al.,
2000).
One of the most common health effects of drug misuse discussed in the literature is
dependence. Dependence is not only a problem in its own right, but can lead to the
continuation and exacerbation of other problems associated with drug misuse. It also
makes desistance from drug use harder and can lead to drug misuse dominating users’
lives. Information provided by a survey conducted by the Office of National Statistics
(ONS) of psychiatric morbidity among 10,000 adults in Great Britain showed that the
lifetime prevalence of dependence in the general population for any illicit drug was 4
per cent (Singleton et al., 2003). Most people who were classified as dependent said that
they were dependent on cannabis (3 per cent of the population) and most scored “1”, the
highest possible score on a five-point scale of levels of dependence. A survey of female
prisoners conducted in 2001 found that almost half of the women interviewed reported
being dependent on at least one drug and the most common drug of dependence was
heroin (33 per cent of inmates) and crack (24 per cent of all inmates) (Borrill et al., 2003).
Another health problem relates to the practice among drug users of intravenous
injection. Many drug users (especially those dependent on heroin) choose to administer
their drugs this way. This is potentially a very harmful way of administering drugs for
a number of reasons. It carries various kinds of health risk to the user such as
abscesses, blood clots, septicaemia, and the risk of overdose. It also carries various
kinds of health risk to others, including cross infection when equipment is shared,
health problems relating to the disposal of used syringes, and the spread of diseases
such as the HIV virus. The prevalence of injecting in the drug user population has been
investigated through the statistics collected as part of the Regional Drug Misuse
Database of clients attending treatment facilities. According to the published statistics,
65 per cent of drug users had injected a drug. Men were more likely than women to
have done so and older users were more likely than younger users to have injected
(Department of Health, 2002). The Unlinked Anonymous Prevalence Monitoring
Program (UAPMP) of drug users attending agencies in the UK in 2004 showed that in
London one in 29 male and one in 20 female injecting drug users were HIV infected
(Health Protection Agency, 2005).
Overall, the research shows that non-medical use of drugs is associated with various
health problems that are a burden not only on the user but on society generally.
Unfortunately, the research does not always breakdown the findings by age and it is
difficult to know which problems are experienced by young drug users in particular.
The research also tends to be based on users in treatment. Much less is known about
drug users who do not present for treatment and drug users who have multiple social
problems and might not wish to be known to the authorities.
One of the most problematic and hard-to-reach groups is drug-misusing offenders.
The most common method of obtaining the views of offenders is to interview prisoners.
A more innovative and recent method is to interview and conduct urine tests on
arrestees at the first point of contact with the criminal justice system and, for some, at
the first point of contact with any treatment agency. The current paper presents the
findings of a study based on interviews and urine specimen collection among
drug-misusing arrestees. The aim of the paper is to identify and compare health
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problems and treatment needs among younger and older arrestees and to draw out the
implications of the findings for health education and prevention.
Methods
This analysis is based on data collected as part of the New English and Welsh Arrestee
Drug Abuse Monitoring (NEW-ADAM) programme. The data used for the analyses
presented in this paper were collected over the last two years of the three-year
programme from May 2000 to March 2002. During this time, surveys were conducted
in 16 custody suites in 13 police force areas across England and Wales. The surveys
were based on arrestees currently held for official processing (usually in relation to a
suspected offence). Arrestees were selected for interview over a 24-hour period for
seven days a week during the survey period of approximately 30 days. The surveys
aimed to sample 100 per cent of arrestees considered eligible for interview. Arrestees
were deemed ineligible if they were unfit for interview, unable to comprehend the
interview or provide informed consent, a potential danger to the interviewer, or under
the age of 17. Arrestees were also excluded if they had been in custody for more than 48
hours or if they were not at liberty prior to entering the custody suite. The subjects
included male and female arrestees. Further details of the methods used can be found
in Holloway and Bennett (2004).
A total of 9,499 arrestees were processed through the 16 custody suites during the
30-day periods of each survey. About 60 per cent of these arrestees (5,628) were deemed
eligible for interview and approximately 64 per cent of all eligible arrestees (3,618) were
approached for interview. The main reason for non-approach was that there was
insufficient time before their release to conduct the interview. Overall, 87 per cent of
arrestees approached (3,135) agreed to be interviewed. Details of the achieved sample
are shown in Table I. Overall, 49 per cent of the sample were aged 17 to 24 (henceforth
referred to as the “younger” group) and 51 per cent were aged 25 and above (the “older”
group). Among the younger group, 86 per cent were male, three-quarters were white,
and 40 per cent had been arrested on suspicion of committing a property (theft) offence.
The main method of data collection was a personal interview using a structured
questionnaire. The questionnaire included (among other things) questions on use of 19
illicit drug types and offending behaviour in relation to ten offence types. The 19 drugs
included heroin, crack and cocaine, and a range of other drugs, including cannabis,
amphetamines, ecstasy, diazepam, and temazepam. Arrestees were asked to report
only illicit use of these drugs and not licit use as a result of obtaining them on
prescription. They were asked about drug misuse ever, in the last 12 months, in the last
30 days and in the last three days.
In addition to completing the questionnaire, arrestees were also asked to provide a
urine specimen that would be analysed for the presence of seven drug types: cannabis,
opiates (including heroin), cocaine (including crack), benzodiazepines, amphetamines,
methadone and alcohol. Prior to the interview, arrestees who had agreed to participate
in the survey were advised that at the end of the interview they would be asked to
provide a urine specimen. The arrestees were informed that providing a specimen was
voluntary and that they would be interviewed even if they did not provide a specimen.
They were also reassured that the results of the urinalysis would be treated in strict
confidence. Ninety per cent of interviewed arrestees (2,833) provided specimens.
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Results
Urinalysis
Of the 1,388 young arrestees (aged 17-24) who provided a urine specimen, almost
three-quarters (72 per cent) tested positive for at least one of the five illicit drug types.
Over one-third (34 per cent) tested positive for two or more drug types. Significantly
more younger than older arrestees tested positive for cannabis, while significantly
more older than younger arrestees tested posive for benzodiazepines, opiates
(including heroin), and cocaine (including crack). There was no significant difference in
the proportion of younger and older arrestees testing positive for alcohol. These
findings are consistent with the view that younger arrestees are more likely than older
ones to have recently used “recreational” drugs, while older arrestees are more likely
than younger ones to have used “habitual” drugs (see Table II).
Self-reported drug use in the last 12 months
The association between higher prevalence of recreational drug use among younger
arrestees and higher prevalence of habitual drug use among older arrestees is also
identified in the self report results (see Table III). Younger arrestees were more likely
than older arrestees to report using cannabis, amphetamines and ecstasy in the last 12
months, whereas older arrestees were more likely to report using heroin, crack and
methadone. This pattern of findings was true for both male and female arrestees. The
only signficant gender difference was that younger females were no less likely than
older females to have used heroin and crack. For further discussion on variations in
drug use by gender see Holloway and Bennett (2007). Significantly more younger than
older arrestees reported using one or more of the drugs listed (excluding alcohol) in the
last 12 months and were more likely to report multiple drug use.
Younger 17-24
(per cent)
Older 25 or more
(per cent)
Total
(per cent) Sig. of difference
Sex
Male 86 86 86 ns
Female 15 14 14
Ethnic group
White 76 82 79 * * *
Non-white 24 18 21
Marital status
Single 85 53 68 * * *
Other 15 47 32
Employment status
Unemployed 49 44 47 * *
Other 51 56 53
Offence arrested for
Property (theft) offence 40 38 39 ns
Other offence 60 62 61
Total n ¼ 3,135 1,547 1,588 3,135
Notes: Includes all arrestees (n ¼ 3,135). ns ¼ not significant, *p , 0:05; * *p , 0:01; * * *p , 0:001.
Some missing cases
Table I.
Demographic
characteristics of younger
and older arrestees
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Overall, the results show an extremely high prevalence of drug use among this sample
of young arrestees. Over one-quarter reported using heroin, cocaine powder, or crack in
the previous 12 months and almost 90 per cent reported using alcohol.
Rate of drug use in the last 30 days
In order to examine rate of use, respondents were asked to estimate the number of days
over the last 30 days that they used each of the drugs types reported. Rates of 15 days
or more were recorded as “high” (on the grounds that this amounted at least to use
every other day) and rates below this were recorded as “low”. The results show that
almost three-quarters of both younger and older arrestees consumed one or more drug
types in the last 30 days at a high rate. Young people were significantly more likely
than old people to report using cannabis at a high rate. Older arrestees were
signficiantly more likely than younger arrestees to report using cocaine powder at a
Younger 17-24
(per cent)
Older 25 or more
(per cent)
Total
(per cent)
Sig. of
difference
Cannabis 55 41 48 * * *
Amphetamines 6 6 6 ns
Benzodiazepines 10 20 15 * * *
Opiates (including heroin) 27 38 33 * * *
Cocaine (including crack) 21 30 26 * * *
Alcohol 22 24 23 ns
Any drug1 72 66 69 * *
Multiple drugs2 34 43 39 * * *
Total n ¼ 2,833 1,388 1,445 2,833
Notes: Includes all arrestees who provided urine specimens (n ¼ 2; 833). ns ¼ not significant,
*p , 0:05; * *p , 0:01; * * *p , 0:001. 1Any drug ¼ positive test result for one or more of cannabis,
amphetamines, benzodiazepines, opiates or cocaine; 2Multiple drugs ¼ positive test result for two or
more of cannabis, amphetamines, benzodiazepines, opiates or cocaine
Table II.
Urinalysis results
Younger 17-24
(per cent)
Older 25 or more
(per cent)
Total
(per cent)
Sig. of
difference
Cannabis 76 60 67 * * *
Amphetamines 21 18 19 *
Ecstasy 36 19 27 * * *
Heroin 28 37 32 * * *
Cocaine powder 26 25 26 ns
Crack cocaine 27 34 31 * * *
Alcohol 89 84 87 * * *
Any drug1 83 71 77 * * *
Multiple drugs2 57 52 55 * *
Total n ¼ 3,135 1,547 1,588 3,135
Notes: Includes all arrestees (n ¼ 3,135). ns ¼ not significant, *p , 0:05, * *p , 0:01, * * *p , 0:001.
1Any drug ¼ self-reported use of any of the above drugs (excluding alcohol) in the last 12 months.
2Multiple drugs ¼ self-reported use of two or more drugs (excluding alcohol) in the last 12 months
Table III.
Self-reported drug use in
the last 12 months
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high rate. Overall, the results show that, in relation to cannabis and heroin, the
majority of young people reported use at a high rate and in relation to crack and
methadone just under half reported high-rate use. Hence, the problems of drug misuse
among this sample cover both prevalence and incidence of use.
General health
Arrestees were also asked about whether they had visited a GP in the last three days
and the nature of their health problems. Over one-quarter of all arrestees had recently
visited a GP. This included just under one-fifth of young arrestees and over one-third of
older arrestees. The reasons given for attending a GP concerned mental health
problems and drug-related health problems. The most common mental health problem
was depression (50 per cent of younger and 53 per cent of older arrestees) and the most
common drug-related reasons concerned heroin addiction (88 per cent of younger and
79 per cent of older arrestees). Other problems included asthma or respiratory
problems, heart problems, hypertension, kidney or bladder problems, epilepsy and
diabetes.
Injecting
One of the most worrying aspects of drug misuse is the practice of administering drugs
by intravenous injection. This practice carries a wide range of health risks including
septicaemia, abscesses and infections. The research found that one-quarter of younger
arrestees reported injecting one or more drugs in the previous 12 months. This was
significantly higher among young female arrestees (27 per cent) than among young
male arrestees (17 per cent). It was also significantly higher among young white
arrestees (23 per cent) than among young non-white arrestees (4 per cent). The rate of
injecting was highest among arrestees who had used heroin. Just over half of the
younger group had injected heroin in the last year and slightly more among the older
group. Other drugs that were injected included ecstasy, amphetamine, cocaine and
crack.
Sharing equipment
Another practice among drug misusers that carries considerable health risks is the
custom of sharing drug taking equipment (needles and syringes). As part of the
interview, arrestees who reported having injected drugs were asked whether or not
they had shared injecting equipment. The results showed that nearly one-quarter (24
per cent) of all arrestees who had injected drugs in the last 12 months had shared
injecting equipment. This was slightly higher among the younger group of injectors
(25 per cent) than the older group (22 per cent) although the difference was not
statististically signficiant.
Hepatitis
Injecting illegal drugs and sharing equipment can spread infectious diseases. One of
the most common infections contracted by drug misusers is hepatitis (particularly
hepatitis B and C). All arrestees were asked if they they had tested positive for one of
the three forms of hepatitis. Among injectors, 3 per cent of all younger arrestees and 12
per cent of older arrestees said that they had received test results confirming that they
were positive for hepatitis.
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Dependence
Previous research has shown that a proportion of regular drug users become
dependent on their drugs. This proportion increases when users consume addictive
drugs such as heroin and crack. All arrestees who had used drugs in the last 12 months
were asked if they were currently dependent on each of six drug types. Almost half of
older arrestees and over one-third of younger arrestees said that they were currently
dependent on one or more of the six drug types listed (see Table IV). The highest rate of
dependence was linked to heroin use with two-thirds of young heroin users reporting
being dependent on the drug and over 70 per cent of older heroin users.
Treatment
Arrestees who reported using drugs in the last 12 months were asked whether they
were in treatment in the last 12 months. Overall, over 90 per cent of drug-misusing
arrestees said that they were not in treatment in the previous 12 months. The
proportion was significantly higher among younger drug users (95 per cent) than older
users (78 per cent). All arrrestees who were not currently in treatment were asked if
they wanted to be in treatment. Approximately one-third of arrestees currently not in
treatment said that they wanted to be. This percentage was slightly higher among
older (37 per cent) compared with younger (23 per cent) arrestees. The proportion of
arrestees reporting an unmet need for treatment was considerably higher among those
who reported being dependent on one or more drugs (55 per cent of younger and 74 per
cent of older arrestees) than those not dependent (6 and 9 per cent respectively). These
findings are particularly important bearing in mind that it is one of the aims of the
Government’s drugs strategy to get drug-misusing offenders into treatment (Table V).
Discussion
The research has shown that young arrestees experienced a wide range of health
problems. They reported many physical and mental health ailments that required them
to visit a GP. Some reported having hepatitis. The majority were drug users and the
majority of these used drugs at a high rate. Many were physically or psychologically
dependent on one or more drugs. A notable proportion administered their drugs by
intravenous injection and a proportion of these shared their drug-using equipment with
Younger 17-24
(per cent)
Older 25 or more
(per cent)
Total
(per cent)
Sig. of
difference
Ecstasy 2 1 2 ns
Cannabis 17 12 15 * *
Amphetamines 4 5 5 ns
Cocaine 1 5 3 * *
Crack 27 37 32 * *
Heroin 66 72 70 *
Any drug1 38 48 43 * * *
Total n ¼ 2,403 1,280 1,123 2,403
Notes: Includes only those arrestees who reported use of the specified drug type in the last 12 months.
ns ¼ not significant, *p , 0:05, * *p , 0:01, * * *p , 0:001. 1Any drug ¼ self-reported dependence on
any of ecstasy, amphetamines, cannabis, crack, heroin or cocaine in the last 12 months
Table IV.
Current dependence on
selected drug types
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other drug users. Despite all of their various health risks and health problems, fewer
than ten per cent said that they were currently receiving any kind of drug treatment.
Drug misuse among the criminal population and its links to crime and other
personal and social problems are issues addressed specifically by the Government’s
drugs strategy. It is appropriate, therefore, to consider the extent to which the
provisions implemented as part of this strategy might be effective in reducing the
drug-related health problems identified above.
The source document of the current drugs strategy, discusses two main approaches
to preventing drug misuse and its associated problems among offenders (“Updated
Drug Strategy, 2002”, Home Office, 2002). The first is prevention which aims to reduce
the likelihood of young people starting drug misuse and to reduce the rate of escalation
of early drug misuse among those who have started. This is implemented primarily
through health education in schools and public information campaigns. The second is a
harm-reduction approach which aims to reduce the negative effects of drug misuse
among those who have already become substantially involved in drugs. This is
implemented at various stages within the criminal justice system mainly through the
use of drug treatment.
Health education interventions
The Updated Drugs Strategy (Home Office, 2002) identified two national programmes
aimed at preventing young people from misusing drugs. The first is the programme of
drug education in schools implemented as a statutory part of the National Curriculum
and supported by Schools Drug Advisors who help develop and deliver the
programme. The second is a public information and education programme called “Talk
to Frank”. This is a Home Office funded media campaign, which aims to provide
relevant information about drugs and drug misuse to young people, their families and
the general public. While these approaches would not have a direct effect on the
problems identified above among drug misusing offenders, it might help prevent
young people from initiating drug use and crime careers.
Younger Older
17-24 (per cent) 25 or more (per cent)
Dependent
Not
dependent
Sig. of
diff. Dependent
Not
dependent
Sig. of
diff.
Currently in drug treatment 10 2 18 7
Currently not in drug treatment 90 98 * * * 82 93 * * *
Total n 484 792 533 588
Currently not in treatment but
would like treatment
55 6 74 9
Currently not in treatment and
would not like treatment
45 94 * * * 26 91 * * *
Total n 434 777 435 548
Notes: Includes all arrestees who reported using cannabis, ecstasy, amphetamines, cocaine, heroin or
crack in the last 12 months (n ¼ 2,403). Dependent ¼ those arrestees who said that they were
currently dependent on one or more of cannabis, ecstasy, amphetamines, cocaine, heroin or crack.
ns ¼ not significant, *p , 0:05, * *p , 0:01, * * *p , 0:001. Some missing cases
Table V.
Need for drug treatment
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Drugs education in schools is a statutory requirement of the National Curriculum
Science Order (Department for Education and Employment and the Qualifications and
Curriculum Authority, 1999). It must be provided in all schools, including special
schools and pupil referral units, and begins at primary school and continues through
each of the key stages (Department for Education and Skills, 2004). The main aims of
drug education are:
. to minimise the number of users who adopt dangerous forms of misuse;
. to persuade those who are experimenting or misusing to stop; and
. to enable pupils who are misusing, or who have concerns about the misuse of
drugs, to seek help (Ofsted, 2005, p. 28).
Official guidance recommends that drug education in the classroom is delivered by
staff who are “confident and skilled in drug issues” (Department for Education and
Skills, 2004, pp. 20-21). However, it is for individual schools to decide precisely how
drug education is organised (Department for Education and Skills, 2004, p. 34).
There have been several evaluations of the effectiveness of school-based drug
education programmes. White and Pitts (1998), for example, conducted a systematic
review of 11 evaluations of school-based interventions and found that ten of the 11
reported a favourable impact on illicit drug use at a one-year follow up. The authors
concluded that the majority of the studies showed positive effect sizes. However, they
noted that programme impacts were often so small as to be of little practical
importance. Ennett et al. (1994)) conducted a systematic review and meta-analysis of
evaluations of the Drug Abuse Resistance Education (DARE) programme. The
programme was designed for school children and was based on a core curriculum of 17
lessons. The aim of the programme was to provide the personal and social skills
necessary to resist the pressure to take drugs. The systematic review was based on 8
studies that met the selection criteria. The results showed that the mean effect size for
all studies combined for tobacco use was positive and statistically significant.
However, no significant effects were reported for alcohol or marijuana use. The author
concluded that the effectiveness of school-based education in changing adolescent drug
use behaviour should not be overstated.
More recently, the National Institute of Health and Clinical Excellence published a
review of systematic reviews on drug use prevention among young people (National
Institute for Health and Clinical Excellence, 2006). The review was based on seven
systematic reviews that were found to be of sufficiently high quality to be included in
the review of reviews. Four of the sevenstudies included school-based prevention
programmes. Each of the four studies found some positive effects in relation to some
elements of the programme. However, the reviewers concluded that the results were
not sufficiently strong to provide proven levels of evidence of effectiveness. The report
concluded that the lack of methodologically sound research evidence made it difficult
to determine whether drug prevention programmes aimed at young people work. The
lack of UK evaluations also made it difficult to draw any conclusions about their
effectiveness in the UK.
In order to address the problem of limited evidence on outcomes, the government
has implemented the Blueprint programme designed to establish a programme of
drug-education in schools and to provide evidence on its effectiveness (Baker, 2006).
The programme is designed for 11-13 year old pupils and involves schools, parents, the
community, health policy and the media. The results of the evaluation have not yet
been published and are expected to be published next year.
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Overall, the use of health education in schools as a means of reducing drug misuse
has not been particularly positive. There are three main reasons for this. The first is
that there have not been many evaluations of the programmes conducted, especially in
the UK. The second is that there have not been many evaluations that are sufficiently
methodologically sound to generate convincing results or to be included in systematic
reviews. The third is that those that are methodologically sound have tended to show
very small effect sizes.
The “Talk to Frank” media campaign comprises a programme of public information
and education aimed to make information on drug misuse available to parents, young
people, and professionals (Home Office, 2007). The programme arose out of the
Updated Drugs Strategy and the decision to replace the National Drugs Helpline with a
project that might have wider appeal. The programme has gone through various
stages of development with different interventions at each stage. The first stage aimed
to build awareness and was based on television and radio advertising campaigns,
posters, youth magazine advertising, and a telephone and web-based helpline. More
recently, the programme has expanded to include public relations activities with
parents, support packs for practitioners, and street marketing campaigns.
The programme has been evaluated by the Frank organisation itself as part of its
periodic reviews. As part of their 2006 review, the organisation commissioned a
nationally representative survey of young people and parents (Home Office, 2006). The
results of the survey showed that 39 per cent of young people and 23 per cent of parents
expressed a spontaneous awareness of the Frank campaign and 68 per cent of young
people and 49 per cent of parents said that they were aware when prompted. Further,
29 per cent of young people and 43 per cent of parents said that they are “very likely” to
call Frank in the future if they have queries. Other findings relating to awareness and
perceptions were generally in a favourable direction. However, no information was
provided on the impact of the programme on behavioural changes such as the
prevention of drug misuse or harm reduction.
The results of systematic reviews of the research on the effectiveness of media
campaigns generally have been mixed.
Snyder et al. (2004), for example, conducted a meta-analysis of the results of 48 US
health mass media campaign evaluations. The mean effect size for all studies combined
was r ¼ 0.09, indicating that the average campaign changed behaviour in a positive
direction among approximately 8 per cent of the population. The positive effects were
greatest among seat belts campaigns (r ¼ 0.15), with slightly lower effect sizes for
drinking campaigns (r ¼ 0.09) and smoking campaigns (r ¼ 0.05). The authors
concluded that public health campaigns have small positive effects on behaviour.
However, cessation of an addictive behaviour was generally more difficult to attain
than cessation of non-addictive behaviour. The authors advised that campaign
planners should set only modest goals when using mass media campaigns to change
behaviour.
Derzon and Lipsey (2002) conducted a meta-analysis on the effectiveness of media
campaigns aimed specifically at reducing drug misuse. The review was based on 72
published and unpublished reports of campaigns that were designed to prevent or
reduce substance use among youths. Of the 72 studies, 48 reported outcomes on
substance use behaviour, 39 reported effects on substance use attitudes and 24
reported outcomes on substance use knowledge. The findings on the effect of the
programmes on behaviour showed that samples exposed to mass media campaigns
and those not exposed to interventions (the comparison groups) both reported negative
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outcomes. In other words, substance misuse tended to increase following a media
intervention. The increase was generally less among samples exposed to the media
interventions than those not exposed. This was true for both alcohol use and drugs.
However, tobacco use increased among the exposed samples and reduced among
samples not exposed. The results of the effectiveness of media campaigns on attitudes
and knowledge showed that they were generally associated with positive results.
When campaigns were launched, attitudes and knowledge generally improved. This
occurred among both exposed and non-exposed groups, with the exposed samples
showed greater positive effects than the non-exposed samples.
The authors concluded that, as a result of generally poor evaluation design, it was
difficult to arrive at any substantive conclusions about the effectiveness of media
campaigns. Overall, participant samples exposed to media interventions tended to
show a greater positive change in attitudes and knowledge and a lower negative
change in behaviour than the comparison samples. However, the poor methodological
quality of the studies (in particular in terms of matching experimental and control
conditions) meant that the finding could not be taken as convincing evidence that
media interventions are effective.
Evaluations of media campaigns designed to prevent drug misuse among young
people generally show either small positive effects or small negative effects on drug
use behaviour. Overall, the research to date does not generate conclusive evidence on
the effectiveness of these campaigns in reducing drug misuse.
Treatment interventions
The second arm of the Government’s drugs strategy is to use the criminal justice
system as a means of moving drug-misusing offenders into treatment. The results of
the NEW-ADAM programme showed that less than 10 per cent of drug-misusing
arrestees were currently in drug treatment. Approximately one-third of arrestees not
currently receiving treatment reported an unmet need for treatment. This increased to
over 50 per cent among those arrestees who reported current dependence on one or
more illicit drug types. It is important therefore that treatment services are made
available to this type of drug-misusing offender.
In 2004/2005, the National Drug Treatment Monitoring System (NDTMS) for
England identified a total of 160,453 clients in treatment for substance misuse.
Twenty-four per cent of these (39,301) were aged under 25 and 5 per cent (8,815) were
aged under 18 (National Treatment Agency for Substance Misuse, 2006). The type of
drug problems experienced by younger and older clients was shown to be different.
The most common drug of misuse at entry among those aged under 18 was cannabis
(67 per cent of all clients), whereas, the most common drug of misuse among those aged
18 and over was heroin (67 per cent). The referral sources of young and older clients
also tended to be different. When the client was aged under 18, the referral source was
most commonly the criminal justice system (33 per cent) and “other sources” (36 per
cent). When the client was aged 18 or over the most common source was self referral
(National Treatment Agency for Substance Misuse, 2006).
The most common types of treatment for young drug misusers aged 11-17 over the
period 2003 to 2004 (the most recent data providing an age breakdown) was structured
counselling (52 per cent) followed by specialist prescribing (21 per cent) and ‘other
structured interventions’ (18 per cent) (National Treatment Agency for Substance
Misuse, 2005) Several other reports provide information on the types of treatment
given to young drug misusers. The Department of Health UK Guidelines on clinical
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management noted that drug treatment was different for young people compared with
adults and supported in the case of the latter brief interventions, family-based
interventions and psychosocial approaches (Department of Health, 2007). A research
study by Addaction and Turning Point found that specialist drug treatment for young
people mainly involved counselling, brief interventions, solution-focused therapy,
motivational interviewing, cognitive behavioural theory, relapse prevention, group
work, and alternative therapies (Didlock and Cheshire, 2005). A survey of service
provision for young drug users in Scotland found that the most common services
offered to young people was counselling, followed by other forms of support and
advice. Some young people aged over 16 were offered prescribing services, but these
were usually restricted to rapid reduction (Burniston et al., 2002).
There have been few reviews of research specifically on the effectiveness of drug
treatment for young people. The UK guidelines report on clinical management
concluded that the evidence-based for substance misuse treatment for under-18s in the
UK and the US was “almost non-existent” (Department of Health, 2007, p. 86).
However, the report suggested that evidence on effectiveness of treatment for adults
and young adults might be cautiously extrapolated to those under 18. It recommended
psychosocial treatment interventions for young people who were not physically
dependent on drugs (including motivational therapies, cognitive behavioural
treatments, and family based support) and pharmacological treatment for those
dependent on alcohol, opiates, or benzodiazepines (Department of Health, 2007, p. 87).
A systematic review of the research literature on the effectiveness of drug treatment
specifically for young people (up to age 16) has been conducted by the Effective
Interventions Unit in Scotland (Burniston et al., 2002). The review was based on 11
primary research studies. The interventions identified as having a “strong” or “fairly
strong” effect in reducing drug misuse were: behavioural therapies, counselling, family
therapies, 12-step programmes, and therapeutic communities. Interventions coded as
having a “weak” or “no effect” were health education counselling, school-based
programmes and what was described as “general drug treatment”. The authors
pointed out that some programmes had harmful effects (in the sense of increasing drug
misuse), including school-based life skills programmes.
A more recent study investigated the impact of three different kinds of criminal
justice drug intervention on children and young people (Matrix Research and
Consultancy and the Institute for Criminal Policy Research, Kings College, 2007). The
interventions were implemented as part of the launch of the government’s Drug
Intervention Programme which aimed to reduce drug use and drug-related crime. The
three interventions were arrest referral (ages 10-17), drug testing (ages 14-17), and Drug
Treatment and Testing Requirements (ages 14 and over). The research found that
neither arrest referral nor drug testing were effective in reducing subsequent drug
misuse. There were no findings reported on Drug Treatment and Testing
Requirements on the grounds that there were too few orders implemented during
the time of the research to arrive at a conclusion.
The bulk of research evidence of treatment effectiveness for drug misuse does not
provide a breakdown of outcome by age. Nevertheless, it is worth noting briefly what
this research generally has found in relation the effectiveness of different treatment
modalities. A recent review of this research published by the National Treatment
Agency examined the effectiveness of four categories of treatment: pharmacotherapies,
psychological treatments, rehabilitation and therapeutic communities, and other
interventions (Gossop, 2007). According to the report, methadone maintenance
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treatment was associated with significant reductions in illicit drug, while methadone
reduction treatment was associated with no significant change or increased use of illicit
opioids. Research on the effectiveness of motivational interviewing generally showed
favourable outcomes, with one review of randomised trials reporting an overall
reduction in substance misuse in 11 of 15 studies investigated. Residential
rehabilitation and therapeutic communities were also associated with lower
abstinence rates, with improved outcomes for patients who spent longer in
treatment. Finally, the report reviewed miscellaneous programmes including
detoxification, cannabis treatment, and needle exchange programme. The review
concluded in relation to cannabis treatment for adolescents that evaluations have
produced mixed results, with some studies showing decreased use, some showing no
change, and some showing increased use following treatment (Gossop, 2007).
Overall, evaluations of drug treatment for young people provide some evidence that
some programmes are effective in reducing drug use. In particular, the kinds of
treatment that are currently provided to young people, such as psychosocial
approaches and prescribing, have all been shown to be effective under research
conditions. In practice, this usually means that relative reductions in drug misuse
occurred during the course of the treatment or during a short-term follow-up. Less is
known about the effectiveness of these kinds of treatments on drug misuse in the
longer term.
Conclusions and implications for policy
The paper has argued that young arrestees experience a wide range of health
problems. Some of these are directly related to drug misuse and some are an indirect
product of it. The current drugs strategy tackles drug misuse and its associated
problems in two main ways. The first is to prevent drug misuse among young people
(including potential drug-misusing offenders) by focusing on a programme of drug
education in schools and public information campaigns. The second approach aims to
reduce drug misuse and its associated harms among existing drug-misusing offenders
though drug treatment.
The results of research on the effectiveness of health education in schools and media
campaigns have not been especially encouraging. One of the problems has been the
lack of good-quality research to make a proper assessment. However, the evidence that
does exist tends to show modest benefits in terms of drug use behaviour. There is also
very little research on the longer term effects of these programmes. In order for drugs
education in schools to impact on drug use among young adults the effects would have
to last a long time. They would also have to be targetted at the group of young people
who are most at risk. In practice, these are likely to be excludees, truants and young
people not attending traditional schools. There is little convincing evidence to
demonstrate that the health and other problems of drug-misusing offenders identified
in this research could be significantly reduced using schools programmes and media
campaigns.
The results of research on drug treatment as a means of reducing drug misuse
among young people are more promising. The range of treatment methods currently
applied to young people and young adults have been shown to be effective on the basis
of methodologically sound research methods, including randomised controlled trials.
The problems of the long-term effectiveness of these programmes continues to exist
and in some cases in might be necessary for treatment to be repeated in order to
maintain its effectiveness over time. However, the evidence that currently exists does
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suggest that drug treatment might be an effective means of reducing the health and
other drug-related problems among young people, including drug-misusing offenders.
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